PER 15.0% 11.5¢ percheron therapeutics limited

Older data but interesting ..MS summary, page-8

  1. 3,189 Posts.
    lightbulb Created with Sketch. 569
    Would be nice to have a slice:

    The global market for multiple sclerosis drugs expected to attain $25.3 billion by 2027, steadily growing at a of CAGR 1.5% over forecast period, driven by large number of both existing therapeutics and new entrants in the marketplace.

    https://www.google.com/amp/s/www.ihealthcareanalyst.com/global-multiple-sclerosis-drugs-market/amp/
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.